Cancer Cell Growth Inhibitory Effect of Bee Venom via Increase of Death Receptor 3 Expression and Inactivation of NF-kappa B in NSCLC Cells

(E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5)

(2012) Pushpa Saranya Kollipara et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines

(2012) F Cramer et al.   CANCER GENE THERAPY

Therapeutic nanosystems for oncology nanomedicine

(2012) A. S. Gonçalves et al.   Clinical & Translational Oncology

Bee venom in cancer therapy

(2011) Nada Oršolić   CANCER AND METASTASIS REVIEWS

A novel parthenin analog exhibits anti-cancer activity: Activation of apoptotic signaling events through robust NO formation in human leukemia HL-60 cells

(2011) Ajay Kumar et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Bee venom induces apoptosis through intracellular Ca2+-modulated intrinsic death pathway in human bladder cancer cells

(2011) Siu-Wan Ip et al.   INTERNATIONAL JOURNAL OF UROLOGY

Role of Cell-Death Ligand-Receptor System of Granulosa Cells in Selective Follicular Atresia in Porcine Ovary

(2011) Naoko INOUE et al.   JOURNAL OF REPRODUCTION AND DEVELOPMENT

Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38α MAPK signaling pathway

(2011) Shang-Tao Chien et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway

(2011) Miran Jo et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice

(2010) Jeong-Eun Huh et al.   CANCER LETTERS

Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB

(2010) Sun Mi Kim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth

(2010) Yaxiong Tang et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB

(2010) Mi Hee Park et al.   PROSTATE

Retracted: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

(2009) Shirish M. Gadgeel et al.   CANCER

Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-κB

(2009) Imtiyaz Murtaza et al.   INTERNATIONAL JOURNAL OF CANCER

TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma

(2009) Adrien Daigeler et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Obovatol Enhances Docetaxel-Induced Prostate and Colon Cancer Cell Death Through Inactivation of Nuclear Transcription Factor-κB

(2009) So Yong Lee et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Thiacremonone Augments Chemotherapeutic Agent-Induced Growth Inhibition in Human Colon Cancer Cells through Inactivation of Nuclear Factor- B

(2009) J. O. Ban et al.   MOLECULAR CANCER RESEARCH

Metastasis to Eyelid as Initial Presentation of Non–Small Cell Carcinoma

(2009) Catharina Latz et al.   OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY

Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting IκBα Kinase-NFκB

(2008) Chen Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody

(2008) A. Shanker et al.   JNCI-Journal of the National Cancer Institute

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY